UNLEASH IMMUNO ONCOLYTICS
Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells. UIO-512 is armed with GM-CSF, a potent immune-modulatory cytokine, triggering an immune response towards the tumor. UIO-512 lead indication is in ovarian cancer, follow on indications include other solid tumors such as glio... blastoma, melanoma and pancreatic cancer. Promising pre-clinical results in animal models and fresh human samples of ovarian cancers as well as in melanoma were published in top ranked peer-reviewed publications. Unleash IO is raising $3.5 M to conduct a phase I/II clinical trial in ovarian cancer with oncolytic immunotherapy UIO-512.
UNLEASH IMMUNO ONCOLYTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2015-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.unleash.bio
Total Employee:
1+
Status:
Active
Contact:
314-730-0050
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
SPF Google Apps For Business Hostgator Mail Oracle Cloud A2 Hosting
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Oncolys BioPharma
Oncolys BioPharma investment in Venture Round - Unleash Immuno Oncolytics
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship investment in Grant - Unleash Immuno Oncolytics
Official Site Inspections
http://www.unleash.bio Semrush global rank: 5.33 M Semrush visits lastest month: 1.56 K
- Host name: 69.48.181.160.static.a2webhosting.com
- IP address: 69.48.181.160
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Unleash Immuno Oncolytics" on Search Engine
St. Louis-based Unleash Immuno Oncolytics Attracts …
LOUIS – St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from publicly-traded Japanese company Oncolys …See details»
Unleash Immuno Oncolytics - Crunchbase Company …
Details. Industries. Biotechnology. Medical Device. Therapeutics. Headquarters Regions Midwestern US. Founded Date 2015. Founders David T. Curiel. Operating Status Active. …See details»
Unleash Immuno Oncolytics | LinkedIn
Unleash Immuno Oncolytics | 135 followers on LinkedIn. Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue...See details»
Unleash Immuno Oncolytics Company Profile - Craft
Unleash Immuno Oncolytics is an immune-oncology company developing oncolytic viruses that target the stromal layer of metastatic cancers. Its lead product, UIO-623, is …See details»
Local Immunotherapy Startup Attracts $3 Million Investment
Oncolys, a publicly-traded company on the Tokyo Stock Exchange has invested $3 million into Unleash to advance their lead patented programs UIO-512 and UIO-702 toward …See details»
Unleash Immuno Oncolytics' Leadership Team Team - The Org
The leadership team at Unleash Immuno Oncolytics has a history of experience in the biochemistry and healthcare industries. They have worked as CEOs, VPs, …See details»
Unleash Immuno Oncolytics - Funding, Financials, …
$3M. in funding over 2 rounds. Their latest funding was raised on Feb 19, 2018 from a Venture - Series Unknown round. Unleash Immuno Oncolytics is funded by 2 …See details»
Oncolys BioPharma invests in US Biotech Venture Specialized in ...
By Reuters. February 16, 20181:36 AM PSTUpdated 6 years ago. Feb 16 (Reuters) - Oncolys BioPharma Inc. * Says it will enter into an investment and share transfer …See details»
BRIEF—Oncolys buys into Missouri firm to expand …
19-02-2018 Print. Japan’s Oncolys BioPharma has bought a significant share of Missouri, USA-based Unleash Immuno Oncolytics for $3 million, affording around 27% voting …See details»
Unleash Immuno Oncolytics - Innovation
1 Brookings Drive | St. Louis, MO 63130. [email protected]. Twitter. LinkedIn. Sectors. Diagnostics. Energy & Environment. Med Tech. Physical Sciences. Therapeutics. ©2024 …See details»
Combination Therapy for the Treatment of Shingles with an ...
Feb 1, 2023 3 Unleash Immuno Oncolytics Inc., St. Louis, MO 63110, USA. PMID: 37259374. PMCID: PMC9958712. DOI: 10.3390/ph16020226. Abstract. Practically the …See details»
Japan’s Oncolys invests £3m in adenovirus firm Unleash Immuno …
Feb 20, 2018 Matt Fellows. Unleash Immuno Oncolytics, a US firm focusing on the development of viral biologics in the treatment of cancer, has attracted the attention of …See details»
Imre (Imi) Kovesdi - Chief Scientific Officer - Unleash Immuno ...
About. Senior Science Executive with over 30 years in the research, discovery, and development of therapeutic drugs in both large pharmaceutical and biotechnology …See details»
Unleash Immuno Oncolystics - Products, Competitors, Financials ...
Unleash Immuno Oncolystics is a developer of products aimed at stopping cancer. Its first product, UIO-512, is a cancer-killing virus, or oncolytic virus, that targets malignant cells …See details»
Unleash Immuno Oncolytics will move into the Cambridge …
Feb 18, 2016. Biotech startup Unleash Immuno Oncolytics will soon move into the Cambridge Innovation Center in the Cortex innovation district thanks to a small seed …See details»
Oncolys Invests in US Biotech Venture Specialized in …
Overview of the companies. <Unleash> (1) Name Unleash Immuno Oncolytics, Inc. (2) Address 4320 Forest Park Avenue, Saint Louis, MO 63108 USA. (3) Representative …See details»
Unleashing the power of the immune system to fight cancer
At Oncolytics, we are driven to improve the lives of people with cancer by giving them what matters most: more quality time. To do this, we are developing pelareorep, a unique …See details»
Unleash Immuno Oncolytics - Contacts, Employees, Board …
About. Unleash Immuno Oncolytics has 3 current employee profiles, including CFO Ariel Muslera. Contacts. Job Department. Protected Content. CEO. Non-Management , …See details»
UIO 512 - AdisInsight - Springer
Contact your organization’s admin about adding this content to your AdisInsight subscription. Buy a PDF version of the profile. Request a free trial. Unleash Immuno …See details»
Unleash Immuno Oncolytics - Crunchbase
Companies like Unleash Immuno Oncolytics include Nano Precision Medical, Calimmune, and ExCellThera. STipe Therapeutics Aarhus , Midtjylland , Denmark 2 Contacts 11-50 …See details»